BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer.
Saved in:
| Title: | BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer. |
|---|---|
| Authors: | Rouanne, Mathieu1,2,3, Adam, Julien4,5, Radulescu, Camélia6, Letourneur, Diane1,7, Bredel, Delphine1, Mouraud, Séverine1, Goubet, Anne-Gaëlle1, Leduc, Marion8,9, Chen, Noah2, Tuan Zea Tan10, Signolle, Nicolas11, Bigorgne, Amélie12,13, Dussiot, Michael12, Tselikas, Lambros1, Susini, Sandrine1, Danlos, François-Xavier1, Schneider, Anna K.11, Chabanon, Roman14,15, Vacher, Sophie16, Bièche, Ivan16 |
| Source: | Journal of Clinical Investigation. 6/15/2022, Vol. 132 Issue 12, p1-17. 17p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
